No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study (Abstract)

BMC Endocr Disord
01 Oct 2020
https://pubmed.ncbi.nlm.nih.gov/33004044/

[Met 5]-enkephalin preserves diffusion metrics in EAE mice (Abstract)

Brain Res Bull
December 2020
https://pubmed.ncbi.nlm.nih.gov/33141073/

Cameon LDN and Multiple Sclerosis (MS) (low dose naltrexone) from LDN Research Trust on Vimeo.

Cameon from the USA shares her story of going from 7 years in a wheelchair to walking, after taking Low Dose Naltrexone for 10 months. 

Her speech is slow but improved as one of the symptoms he suffered from Multiple Sclerosis (MS). 

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

Julie Talks about Low Dose Naltrexone (LDN) for Multiple Autoimmune Conditions from LDN Research Trust on Vimeo.

Teresa shares her Fibromyalgia, CFS, Thyroid disfunction, Spondyloarthritis, IBS and LDN Story (low dose naltrexone, LDN) from LDN Research Trust on Vimeo.

Ulrich Lanius, PhD and Galyn Forster, MS, LPC - Opioid Antagonists and Traumatic Brain Injury (2017 Conference) (LDN, low dose naltrexone)

They begin their presentation by discussing Naltrexone and seizure activity, as demonstrated through clinical trials. They found that later dosage adjustments were helpful in reducing the cognitive effects.

Jill Brook M.A. - Dietary Strategies to Fight Autoimmunity (2017 Conference) (LDN, low dose naltrexone)

Jill Brook, MA shares her presentation on Nutrition at the LDN 2017 Conference.

Jarred Younger, PhD - Calming microglia: a future method for treating multiple sclerosis (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Younger's Calming microglia Presentation